Skip menu navigation Home > Listing of Viewable PTMT Reports > Table of Contents for This Set of Reports


U.S. PATENT AND TRADEMARK OFFICE
Patent Technology Monitoring Team (PTMT)

Patenting In Technology Classes,
Breakout By Organization

Count of 2011 - 2015 Utility Patent Grants,
By Calendar Year of Grant
With Patent Counts Based on Primary Patent Classification

- Explanation of Data -

Rank Ordered Listing of Organizations Receiving 5 or More Utility Patents During the Period
Having Primary Classification In

Class 530, Chemistry: Natural Resins or Derivatives; Peptides or Proteins; Lignins or Reaction Products Thereof

( technology class is determined by the primary classification assigned to the patent- see 'Explanation of Data' )
( patent ownership is determined by the first-named assignee listed on a patent )

The following table displays first-named assignees and counts of their associated patents, as distributed by the year of patent grant.
First-Named Assignee 2011 2012 2013 2014 2015 Total
~INDIVIDUALLY OWNED PATENT 27 27 22 18 18 112
GENENTECH, INC. 18 11 20 17 10 76
UNIVERSITY OF CALIFORNIA, THE REGENTS OF 6 12 13 11 17 59
AMGEN, INC. 16 12 9 10 6 53
BAXTER INTERNATIONAL INC. 14 3 5 10 4 36
UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH & HUMAN SERVICES 12 2 8 8 3 33
NOVO NORDISK A/S 4 5 4 10 9 32
WISCONSIN ALUMNI RESEARCH FOUNDATION 3 3 7 10 6 29
XENCOR, INC. 4 10 6 7 2 29
ABBVIE INC. 0 0 3 15 10 28
CHUGAI SEIYAKU KABUSHIKI KAISHA 9 4 5 5 5 28
HOFFMANN-LA ROCHE INC. 4 6 4 11 3 28
NOVARTIS AG (FORMERLY SANDOZ LTD.) 5 9 4 4 5 27
ZYMOGENETICS, INC. 6 7 6 4 1 24
AMBRX, INC. 5 7 3 5 2 22
STANFORD UNIVERSITY 5 5 4 5 3 22
BRISTOL-MYERS SQUIBB COMPANY 5 4 2 3 7 21
IMMUNOMEDICS INC. 5 2 3 5 6 21
KYOWA HAKKO KIRIN CO., LTD. 7 5 6 2 1 21
SCHERING CORP. 15 6 0 0 0 21
AGENSYS, INC. 11 3 4 1 1 20
E. I. DU PONT DE NEMOURS AND COMPANY 10 2 5 3 0 20
MERCK SHARP & DOHME CORP. 2 3 7 6 2 20
UNIVERSITY OF TEXAS 5 4 2 6 3 20
MEDAREX, INC. 4 7 6 0 0 17
NEKTAR THERAPEUTICS 2 5 6 1 3 17
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS 4 2 4 2 4 16
BIOGEN IDEC MA INC. 9 2 1 3 0 15
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 3 1 4 4 3 15
ABBOTT LABORATORIES 5 5 2 1 0 13
BIO-RAD LABORATORIES, INC. 3 3 1 3 3 13
GE HEALTHCARE BIO-SCIENCES AB 0 3 1 4 5 13
HUMAN GENOME SCIENCES, INC. 6 5 2 0 0 13
IMMUNOGEN INC. 3 3 2 3 2 13
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 0 2 6 3 2 13
NOVO NORDISK HEALTH CARE AG 2 1 3 5 2 13
ONCOTHERAPY SCIENCE, INCORPORATED 3 0 5 5 0 13
UNIVERSITY OF PENNSYLVANIA 4 1 1 3 4 13
DANISCO US INC 3 2 2 4 1 12
EMD MILLIPORE CORPORATION 0 3 4 2 3 12
RAMOT AT TEL AVIV UNIVERSITY LTD. 2 5 4 0 1 12
TUFTS UNIVERSITY 3 1 4 3 1 12
WYETH 5 2 2 1 2 12
YEDA RESEARCH AND DEVELOPMENT CO., LTD. 3 2 5 1 1 12
ELI LILLY AND COMPANY 4 5 1 1 0 11
MACROGENICS, INC. 2 3 2 2 2 11
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 3 1 3 2 2 11
MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG 3 2 1 5 0 11
SCRIPPS RESEARCH INSTITUTE 4 4 1 2 0 11
UNITED STATES OF AMERICA, DEPARTMENT OF AGRICULTURE 4 2 2 2 1 11
UNIVERSITY OF ILLINOIS 3 2 3 2 1 11
ABLYNX N.V. 0 2 1 3 4 10
ALLERGAN, INC. 5 3 1 1 0 10
DANA-FARBER CANCER INSTITUTE, INC. 2 2 1 1 4 10
GLAXO GROUP LIMITED 1 3 1 3 2 10
IMMATICS BIOTECHNOLOGIES GMBH 4 4 2 0 0 10
IMMUNEX CORPORATION 6 1 2 1 0 10
INTREXON CORPORATION 2 2 1 3 2 10
JAPAN SCIENCE AND TECHNOLOGY AGENCY 5 0 2 2 1 10
PIONEER HI-BRED INTERNATIONAL, INC. 5 1 3 1 0 10
SENOMYX, INC. 6 2 2 0 0 10
ACADEMIA SINICA 0 3 3 2 1 9
AILERON THERAPEUTICS, INC. 3 0 1 1 4 9
AJINOMOTO COMPANY INCORPORATED 0 0 2 3 4 9
DYAX CORP. 3 2 0 2 2 9
JANSSEN BIOTECH, INC. 0 0 3 3 3 9
JOHNS HOPKINS UNIVERSITY 3 3 1 2 0 9
LUDWIG INSTITUTE FOR CANCER RESEARCH 7 2 0 0 0 9
REGENERON PHARMACEUTICALS, INC. 2 1 1 2 3 9
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 5 3 1 0 0 9
UCB PHARMA S.A. 3 1 3 2 0 9
UNIVERSITY OF MINNESOTA, THE REGENTS OF 2 2 3 1 1 9
CELL SIGNALING TECHNOLOGY, INC. 6 0 1 0 1 8
GENERAL HOSPITAL CORPORATION 2 1 1 2 2 8
HELIAE DEVELOPMENT, LLC 0 0 5 3 0 8
IMMUNOCORE LIMITED 2 3 3 0 0 8
INVENTION SCIENCE FUND I, LLC 6 0 0 1 1 8
JNC CORPORATION 0 0 1 5 2 8
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES 1 0 1 2 4 8
LIFE TECHNOLOGIES CORPORATION 1 0 5 1 1 8
MEDIMMUNE LIMITED 3 1 2 1 1 8
MEDIMMUNE, LLC 2 2 1 3 0 8
ROCKEFELLER UNIVERSITY 1 1 3 1 2 8
UNIVERSITY OF WASHINGTON 0 2 0 2 4 8
YALE UNIVERSITY 3 2 1 1 1 8
APOGENIX GMBH 0 0 3 3 1 7
BIOCON LIMITED 4 0 1 1 1 7
CASE WESTERN RESERVE UNIVERSITY 1 2 0 3 1 7
CITY OF HOPE 0 1 1 3 2 7
DSM IP ASSETS B.V. 1 1 2 3 0 7
DUKE UNIVERSITY 2 0 3 2 0 7
ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT, LLC 1 0 3 2 1 7
IPSEN PHARMA S.A.S. 1 2 1 1 2 7
ISIS INNOVATION LIMITED 2 2 1 1 1 7
NATIONAL RESEARCH COUNCIL OF CANADA 3 0 2 1 1 7
PALATIN TECHNOLOGIES, INC. 1 1 2 2 1 7
RIKEN 2 1 3 1 0 7
ROCHE GLYCART AG 0 0 1 4 2 7
SALADAX BIOMEDICAL INC. 2 2 2 0 1 7
UNIVERSITY OF ARKANSAS 1 3 2 1 0 7
UNIVERSITY OF ROCHESTER 1 2 2 1 1 7
ABBVIE BIOTHERAPEUTICS INC. 0 0 3 2 1 6
AMYLIN PHARMACEUTICALS, INC. 2 1 2 0 1 6
ARES-TRADING S.A. 1 2 2 0 1 6
B.R.A.H.M.S GMBH 1 0 3 1 1 6
BIOMERIEUX SA 1 1 2 1 1 6
BRIGHAM AND WOMEN'S HOSPITAL, INC. 3 1 2 0 0 6
CEM CORPORATION 2 2 1 1 0 6
CENTOCOR ORTHO BIOTECH INC. 1 3 2 0 0 6
CENTRE FOR ADDICTION AND MENTAL HEALTH 0 2 2 2 0 6
COLUMBIA UNIVERSITY 2 1 2 0 1 6
CRUCELL HOLLAND, B.V. 1 5 0 0 0 6
CSL BEHRING GMBH 1 0 1 3 1 6
CSL LIMITED 0 2 3 1 0 6
FIVE PRIME THERAPEUTICS, INC. 2 1 2 0 1 6
FUJIFILM CORPORATION 1 1 3 0 1 6
FUSO PHARMACEUTICAL INDUSTRIES, LTD. 2 0 3 0 1 6
INCYTE CORPORATION 2 0 1 3 0 6
MILLENNIUM PHARMACEUTICALS, INC. 2 1 0 2 1 6
NEW YORK UNIVERSITY 1 1 1 1 2 6
NORTHWESTERN UNIVERSITY 0 1 1 3 1 6
NOVOZYMES A/S 1 2 1 2 0 6
PANASONIC CORPORATION 1 0 0 5 0 6
PHILOGEN S.P.A. 1 1 3 1 0 6
PIERRE FABRE MEDICAMENT 1 1 1 3 0 6
STOWERS INSTITUTE FOR MEDICAL RESEARCH 1 2 2 1 0 6
SYNERGY PHARMACEUTICALS, INC. 0 1 3 1 1 6
THE UNIVERSITY OF TOKYO 1 1 2 0 2 6
UNIVERSITY OF COLORADO, THE REGENTS OF 0 1 0 4 1 6
UNIVERSITY OF MASSACHUSETTS 2 2 1 0 1 6
AMSILK GMBH 3 0 0 2 0 5
AVEO PHARMACEUTICALS, INC. 0 0 4 1 0 5
AXELLIA PHARMACEUTICALS APS 0 2 0 0 3 5
CANON KABUSHIKI KAISHA 2 0 1 0 2 5
CHILDREN'S MEDICAL CENTER CORPORATION 0 1 0 4 0 5
DAIICHI SANKYO COMPANY, LIMITED 0 1 3 1 0 5
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS 1 2 2 0 0 5
DOW AGROSCIENCES LLC 2 2 0 0 1 5
FERRING B.V. 0 0 1 2 2 5
FLORIDA STATE UNIVERSITY 0 4 0 1 0 5
FUJIFILM MANUFACTURING EUROPE B.V. 2 3 0 0 0 5
GENCIA CORPORATION 1 0 2 0 2 5
GENERAL ELECTRIC COMPANY 2 1 1 1 0 5
GENZYME CORPORATION 0 1 2 2 0 5
GLAXOSMITHKLINE BIOLOGICALS S.A. 1 0 0 1 3 5
IDEXX LABORATORIES, INC. 0 3 2 0 0 5
INSTITUT PASTEUR 0 2 0 3 0 5
ISP INVESTMENTS INC. 0 1 3 1 0 5
LPATH INC. 2 1 1 1 0 5
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V 0 0 0 4 1 5
MEDAREX, L.L.C. 0 0 1 4 0 5
MOCHIDA PHARMACEUTICAL CO., LTD. 1 2 2 0 0 5
MOMENTA PHARMACEUTICALS, INC. 1 1 0 3 0 5
MORPHOTEK, INC. 0 1 2 1 1 5
NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY 1 0 0 3 1 5
OCTAPHARMA AG 1 1 1 1 1 5
ONCOMED PHARMACEUTICALS, INC. 1 2 1 1 0 5
OSAKA UNIVERSITY 1 0 1 0 3 5
PFIZER INC. 1 2 1 1 0 5
SANDOZ AG 1 1 2 1 0 5
SHANGHAI TECHWELL BIOPHARMACEUTICAL CO., LTD 0 0 0 1 4 5
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH 3 1 0 1 0 5
SPIBER TECHNOLOGIES AB 0 2 1 2 0 5
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0 0 2 1 2 5
UAB RESEARCH FOUNDATION 2 0 0 3 0 5
UNITED STATES OF AMERICA, NAVY 1 2 1 0 1 5
UNIVERSITY OF IOWA RESEARCH FOUNDATION 0 2 1 2 0 5
UNIVERSITY OF MICHIGAN 0 1 0 2 2 5
UNIVERSITY OF TOLEDO 1 1 0 2 1 5
UNIVERSITY OF UTAH RESEARCH FOUNDATION 0 1 3 1 0 5
VASGENE THERAPEUTICS, INC. 2 1 0 0 2 5
WASHINGTON UNIVERSITY 0 2 3 0 0 5



PTMT Contacts

Questions regarding these reports should be directed to:

U.S. Patent and Trademark Office
Electronic Information Products Division - PTMT
P.O Box 1450
Alexandria VA 22313-1450

tel: (571) 272-5600
fax: (571) 273-0110
email: oeip@uspto.gov

address of PTMT pages at the USPTO Web Site: http://www.uspto.gov/web/offices/ac/ido/oeip/taf/reports.htm
selected PTMT files available for download at : http://www.uspto.gov/web/offices/ac/ido/oeip/taf/data/


Top

Skip menu navigation Home > Listing of Viewable PTMT Reports > Table of Contents for This Set of Reports